Ancef (Cefazolin) Coverage and Dosing
Ancef (cefazolin) is a first-generation cephalosporin that provides excellent coverage against methicillin-susceptible Staphylococcus aureus (MSSA), streptococci including Streptococcus pneumoniae, and many gram-negative organisms including Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis, but lacks activity against MRSA, enterococci, and most anaerobes. 1, 2
Antimicrobial Spectrum
Gram-Positive Coverage
- Highly effective against MSSA - this is a primary indication for cefazolin 1, 3
- Excellent activity against Streptococcus pneumoniae and Group A/B streptococci 1, 2
- Does NOT cover MRSA - alternative agents like vancomycin or linezolid must be used if MRSA is suspected 3
- Does NOT cover enterococci 2
Gram-Negative Coverage
- Good activity against E. coli and Klebsiella species (4-8 fold more active than other first-generation cephalosporins) 4, 5
- Covers Proteus mirabilis effectively 5, 6
- Limited activity against indole-positive Proteus species 5
- Does NOT cover Pseudomonas aeruginosa or other non-fermenting gram-negatives 2
Anaerobic Coverage
- Minimal to no anaerobic coverage - not appropriate for infections requiring anaerobic coverage 2
Standard Dosing Regimens
Adult Dosing for Infections
For MSSA skin and soft tissue infections: 1 gram IV every 8 hours 1, 3
For moderate to severe infections: 500 mg to 1 gram IV every 6-8 hours 2
For severe, life-threatening infections (endocarditis, septicemia): 1-1.5 grams IV every 6 hours 2
For mastitis: 1 gram IV every 8 hours for 7-10 days (increase to 2 grams every 8 hours for severe infections) 3
For mild infections from susceptible gram-positive cocci: 250-500 mg IV every 8 hours 2
For uncomplicated UTI: 1 gram IV every 12 hours 2
For pneumococcal pneumonia: 500 mg IV every 12 hours 2
Surgical Prophylaxis Dosing
Standard surgical prophylaxis: 2 grams IV administered 30-60 minutes prior to incision, with redosing of 1 gram if procedure duration exceeds 4 hours 7
For cardiac surgery: 2 grams IV plus 1 gram in cardiopulmonary bypass priming solution, with redosing of 1 gram at the 4th hour intraoperatively 7
For neurosurgery/spine surgery with implants: 2 grams IV as single dose, with redosing of 1 gram if duration exceeds 4 hours 7
For urologic procedures: 1 gram IV every 8 hours 7
Postoperative prophylaxis: 500 mg to 1 gram IV every 6-8 hours for 24 hours postoperatively (may extend to 3-5 days for high-risk procedures like open-heart surgery or prosthetic arthroplasty) 2
Pediatric Dosing
For mild to moderate infections: 25-50 mg/kg/day divided every 8 hours (or every 6 hours) 2
For severe infections: Up to 100 mg/kg/day divided every 8 hours 2
For staphylococcal infections: 33 mg/kg/dose IV every 8 hours (or 150 mg/kg/day divided every 8 hours) 1, 7, 3
For infective endocarditis: 100 mg/kg/day IV divided every 8 hours (maximum 12 grams daily) 1, 7
For CNS infections: 100 mg/kg/day divided every 8 hours to ensure adequate CNS penetration 7
For GBS prophylaxis in neonates (maternal dosing): 2 grams IV initial dose, then 1 gram IV every 8 hours until delivery 1
Safety note: Not recommended for premature infants and neonates due to lack of established safety data 2
Renal Dose Adjustments
Critical consideration: Failure to adjust dosing in renal impairment can lead to drug accumulation, neurotoxicity, and seizures 8
CrCl ≥55 mL/min or SCr ≤1.5 mg/dL: Full dose with no adjustment 2
CrCl 35-54 mL/min or SCr 1.6-3.0 mg/dL: Full dose but extend interval to at least every 8 hours 2
CrCl 11-34 mL/min or SCr 3.1-4.5 mg/dL: Give 1/2 usual dose every 12 hours (after loading dose) 2
CrCl ≤10 mL/min or SCr ≥4.6 mg/dL: Give 1/2 usual dose every 18-24 hours (after loading dose) 2
Pharmacokinetic Advantages
- Prolonged half-life: 2 hours (versus 1.4 hours for cephaloridine), allowing for less frequent dosing 4
- High serum levels: Achieves peak concentrations of 38.8 mcg/mL after 1 gram IM, with detectable levels at 8 hours 4, 6
- Good tissue penetration: Effective penetration into breast tissue and other soft tissues 3, 6
- High protein binding: 81% protein-bound, which may reduce free drug activity in serum but contributes to sustained levels 4
- Painless IM administration: Unlike other cephalosporins, cefazolin causes minimal pain with intramuscular injection 5, 6
Critical Pitfalls and Caveats
Dosing Errors
- Never confuse cefazolin with ertapenem - ertapenem is dosed once daily, while cefazolin requires every 6-8 hour dosing for most infections 1
- Do not use once-daily dosing except in specific surgical prophylaxis contexts - this leads to subtherapeutic trough levels 1
- Always adjust for renal dysfunction - a case report documented fatal seizures from excessive dosing (2 grams every 4 hours instead of every 12 hours) in a patient with renal impairment 8
Coverage Limitations
- Failure to cover MRSA will result in treatment failure - if MRSA is suspected or confirmed, switch to vancomycin or linezolid 3
- Inadequate for abscess without drainage - antibiotics alone will fail if surgical drainage is not performed 3
- Not effective for anaerobic infections - add metronidazole or use alternative agents for polymicrobial infections 2
Monitoring Requirements
- Clinical response should occur within 48-72 hours - if no improvement, obtain cultures, broaden coverage, or evaluate for complications like abscess formation 3
- Monitor renal function especially in elderly patients, those with pre-existing CNS conditions, or baseline renal impairment, as these factors potentiate neurotoxicity risk 8
Penicillin Allergy Considerations
- Cefazolin can be safely used in most patients with penicillin allergy, though cross-reactivity concerns have historically led to use of less effective alternatives 9
- For severe beta-lactam allergy, use vancomycin (30 mg/kg/day in 2 divided doses) or clindamycin (600-900 mg IV every 8 hours) as alternatives 3